ARID1A and familial pancreatic carcinoma: To confirm the clinical relevance of our findings, we analysed ARID1A and FASN expression in a pancreatic cancer cohort from The Cancer Genome Atlas (TCGA) dataset and observed a negative correlation between ARID1A and FASN expression (Figure S5).